The respiratory microbiome in patients with post-COVID-19 residual lung abnormalities resembles that of healthy individuals and is distinct from idiopathic pulmonary fibrosis.

Saved in:
Bibliographic Details
Title: The respiratory microbiome in patients with post-COVID-19 residual lung abnormalities resembles that of healthy individuals and is distinct from idiopathic pulmonary fibrosis.
Authors: Smith DJF; National Heart and Lung Institute, Imperial College London, London, UK.; Royal Brompton & Harefield Hospitals, London, UK.; Imperial College Healthcare NHS Trust, London, UK., Teng NMY; National Heart and Lung Institute, Imperial College London, London, UK., Denneny EK; University College London, London, UK.; University College London Hospitals NHS Foundation Trust, London, UK., Mehta P; University College London, London, UK.; University College London Hospitals NHS Foundation Trust, London, UK., Stanel SC; University of Manchester, Manchester, UK.; Manchester University NHS Foundation Trust, Manchester, UK., Blaikley JF; University of Manchester, Manchester, UK.; Manchester University NHS Foundation Trust, Manchester, UK., Chambers RC; University College London, London, UK., Chaudhuri N; Ulster University, Belfast, UK., Garfield B; Royal Brompton & Harefield Hospitals, London, UK., Garner JL; National Heart and Lung Institute, Imperial College London, London, UK.; Royal Brompton & Harefield Hospitals, London, UK., George PM; National Heart and Lung Institute, Imperial College London, London, UK.; Royal Brompton & Harefield Hospitals, London, UK., Ghai P; National Heart and Lung Institute, Imperial College London, London, UK., Kon OM; National Heart and Lung Institute, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK., Li Y; Division of Pulmonary and Critical Care Medicine, New York University, New York, NY, USA., Man WD; National Heart and Lung Institute, Imperial College London, London, UK.; Royal Brompton & Harefield Hospitals, London, UK.; King's Centre for Lung Health, Faculty of Life Sciences and Medicine, King's College London, London, UK., Porter JC; University College London, London, UK.; University College London Hospitals NHS Foundation Trust, London, UK., Quinn V; National Heart and Lung Institute, Imperial College London, London, UK., Rivera-Ortega P; Manchester University NHS Foundation Trust, Manchester, UK., Ross C; Imperial College Healthcare NHS Trust, London, UK., Segal LN; Division of Pulmonary and Critical Care Medicine, New York University, New York, NY, USA., Walker SA; National Heart and Lung Institute, Imperial College London, London, UK., Wu BG; Division of Pulmonary and Critical Care Medicine, New York University, New York, NY, USA.; Department of Veteran Affairs, New York Harbor Healthcare System, New York, NY, USA., Lloyd CM; National Heart and Lung Institute, Imperial College London, London, UK., Stewart I; National Heart and Lung Institute, Imperial College London, London, UK., Jenkins RG; National Heart and Lung Institute, Imperial College London, London, UK.; Royal Brompton & Harefield Hospitals, London, UK., Molyneaux PL; National Heart and Lung Institute, Imperial College London, London, UK.; Royal Brompton & Harefield Hospitals, London, UK.
Source: ERJ open research [ERJ Open Res] 2025 May 27; Vol. 11 (3). Date of Electronic Publication: 2025 May 27 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2312-0541
DOI:10.1183/23120541.00826-2024